Clinical Trial Update: Acetyl-L-Carnitine in the Treatment of Septic Shock [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated acetyl-L-carnitine for septic shock and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: Vanderbilt University | Conditions: Septic Shock | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-06-08